Related Experiment Video
Updated: Jun 13, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Medicaid prescription drug utilization and expenditures following Part D
Joel F Farley1, Stacie B Dusetzina
1University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA. jffarley@unc.edu
Objectives:
Although much attention has been paid to examining the impact of Medicare Part D on Medicare, few studies have examined its influence on Medicaid. This study uses an interrupted time series design to examine the impact of Part D on prescription drug expenditures and utilization among different therapeutic classes of medication across 44 Medicaid programs. In overall reductions in Medicaid prescription expenditures and utilization, our study finds evidence of greater reductions among medications used to treat chronic conditions. Our results provide a glimpse of the impact of Part D on long-term growth in the Medicaid prescription drug benefit.
More Related Videos
06:55Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Dosage Regimens: Designs and Approaches
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...